Use of plasma circulating tumour DNA to detect epidermal growth factor receptor (EGFR) mutations: results from a ctDNA service in the north-west of England.
Affiliation
Medical Oncology, The Christie NHS Foundation Trust, ManchesterIssue Date
2018-01
Metadata
Show full item recordCitation
Use of plasma circulating tumour DNA to detect epidermal growth factor receptor (EGFR) mutations: results from a ctDNA service in the north-west of England 2018, 115:S18 Lung CancerJournal
Lung CancerDOI
10.1016/S0169-5002(18)30071-0Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0169500218300710Type
Meetings and ProceedingsLanguage
enISSN
01695002ae974a485f413a2113503eed53cd6c53
10.1016/S0169-5002(18)30071-0